This inventor holds 11 USPTO granted patents and 14 published patent applications, plus 4 CIPO patents and 5 EPO patents. Top assignees: Hanmi Pharm. Co., Ltd., Hanmi Science Co., Ltd.. Active years: 2016-2025.
Location History:
- Hanam-si, KR (2016)
- Seoul, KR (2016)
- Hwaseong-si, KR (2018 - 2022)
- Gyeonggi-do, KR (2019 - 2023)
Company Filing History:
Years Active: 2016-2025
Title: Euh Lim Oh: Innovator in Immunostimulatory IL-2 Analogs
Introduction
Euh Lim Oh is a prominent inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of immunology, particularly through his work on interleukin-2 (IL-2) analogs. With a total of 11 patents to his name, his innovations have the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Euh Lim Oh's latest patents focus on immunostimulating IL-2 analogs. These patents disclose modifications to interleukin-2 alpha receptors, enhancing their binding affinity for interleukin-2 beta receptors. His work on these analogs aims to improve the efficacy of IL-2 in therapeutic applications, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Euh Lim Oh has worked with notable companies such as Hanmi Pharm Co., Ltd. and Hanmi Science Co., Ltd. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Euh Lim Oh has collaborated with esteemed colleagues, including Se Chang Kwon and Sung Youb Jung. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Euh Lim Oh's contributions to the field of immunology through his patents on IL-2 analogs highlight his role as a key innovator. His work not only advances scientific understanding but also holds promise for future therapeutic developments.